Aciclovir transdermal - Transport Pharmaceuticals

Drug Profile

Aciclovir transdermal - Transport Pharmaceuticals

Alternative Names: SoloVir

Latest Information Update: 31 May 2012

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Transport Pharmaceuticals
  • Class Antivirals; Hypoxanthines; Small molecules
  • Mechanism of Action DNA-directed DNA polymerase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Herpes simplex virus infections

Most Recent Events

  • 31 May 2012 Discontinued - Phase-III for Herpes simplex virus infections in USA (Transdermal)
  • 28 Nov 2007 Efficacy and safety data from a phase II trial (TPI-H-221) in recurrent herpes labialis released by Transport Pharmaceuticals
  • 01 May 2007 Transport Pharmaceuticals initiates dosing in a phase II trial (TPI-H-221) for recurrent herpes labialis in the US
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top